Skip to main content

06.09.2024

Development of an Intervention Targeted to Patients with Cancers Not Typically Perceived as Smoking-Related

verfasst von: Ursula Martinez, Thomas H. Brandon, Cherell Cottrell-Daniels, Colleen M. McBride, Graham W. Warren, Cathy D. Meade, Amanda M. Palmer, Vani N. Simmons

Erschienen in: Journal of Cancer Education

Einloggen, um Zugang zu erhalten

Abstract

Smoking by cancer patients impairs treatment outcomes and prognoses across cancer types. Previous research shows greater smoking cessation motivation and quit rates among patients with cancers strongly linked to smoking (i.e., thoracic, head and neck) compared to other cancer types (e.g., melanoma). Therefore, there is a need to increase cessation motivation among patients with malignancies less commonly associated with smoking. Yet, no targeted educational materials exist to meet this information gap. This manuscript describes the development of theory-based self-help educational materials, targeted by cancer type, to increase motivation to quit smoking among patients with cancers not widely perceived as smoking-related (i.e., breast, melanoma, bladder, colorectal, gynecological). Using a three-phase iterative process, we first conducted in-depth interviews with our intended audience (N = 18) to identify information needs and nuanced content. Themes included patients’ low knowledge about the connection between smoking and cancer etiology and outcomes; negative affect, habit, dependence, and weight gain as quitting barriers; and a preference for positive and non-judgmental content. Second, content creation was based on interview findings, the scientific literature, and framed following the teachable moment model. Last, learner verification and revisions via interviews with 22 patients assessed suitability of draft materials, with generally favorable responses. Resulting edits included tailoring cost savings to the cancer context, explaining cessation medications, and increasing appeal by improving the diversity (e.g., race) of the individuals in the photographs. The final booklets are low cost, easy to disseminate, and—pending efficacy studies—may expand smoking cessation to a wider spectrum of cancer patients.
Literatur
1.
Zurück zum Zitat U.S. Department of Health and Human Services (2014) The health consequences of smoking: 50 years of progress. A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health U.S. Department of Health and Human Services (2014) The health consequences of smoking: 50 years of progress. A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
2.
Zurück zum Zitat U.S. Department of Health and Human Services (2020) Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health U.S. Department of Health and Human Services (2020) Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
3.
Zurück zum Zitat Schnoll RA et al (2003) Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 21:355–365CrossRefPubMed Schnoll RA et al (2003) Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 21:355–365CrossRefPubMed
4.
Zurück zum Zitat Wakefield M et al (2004) Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial. Nurs Res 53:396–405CrossRefPubMed Wakefield M et al (2004) Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial. Nurs Res 53:396–405CrossRefPubMed
5.
Zurück zum Zitat Berg CJ et al (2013) Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology 22:799–806CrossRefPubMed Berg CJ et al (2013) Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology 22:799–806CrossRefPubMed
6.
Zurück zum Zitat Martínez Ú et al (2018) Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psychooncology 27:2104–2110CrossRefPubMedPubMedCentral Martínez Ú et al (2018) Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psychooncology 27:2104–2110CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Myrie AK, Matulewicz RS (2021) Perceptions of the link between smoking and bladder cancer among United States adults. J Urol 205:324–326CrossRefPubMed Myrie AK, Matulewicz RS (2021) Perceptions of the link between smoking and bladder cancer among United States adults. J Urol 205:324–326CrossRefPubMed
9.
Zurück zum Zitat Pineiro B et al (2018) Systematic transcreation of self-help smoking cessation materials for Hispanic/Latino smokers: improving cultural relevance and acceptability. J Health Commun 23:350–359CrossRefPubMedPubMedCentral Pineiro B et al (2018) Systematic transcreation of self-help smoking cessation materials for Hispanic/Latino smokers: improving cultural relevance and acceptability. J Health Commun 23:350–359CrossRefPubMedPubMedCentral
10.
11.
Zurück zum Zitat McBride CM, Emmons KM, Lipkus IM (2003) Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 18:156–170CrossRefPubMed McBride CM, Emmons KM, Lipkus IM (2003) Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 18:156–170CrossRefPubMed
12.
Zurück zum Zitat Heatherton TF et al (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119–1127CrossRefPubMed Heatherton TF et al (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119–1127CrossRefPubMed
13.
Zurück zum Zitat Biener L, Abrams DB (1991) The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 10:360–365CrossRefPubMed Biener L, Abrams DB (1991) The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 10:360–365CrossRefPubMed
14.
Zurück zum Zitat Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20:37–46CrossRef Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20:37–46CrossRef
15.
Zurück zum Zitat Chavarria EA et al (2021) Learner verification: a methodology to create suitable education materials. Health Lit Res Pract 5:e49–e59PubMedPubMedCentral Chavarria EA et al (2021) Learner verification: a methodology to create suitable education materials. Health Lit Res Pract 5:e49–e59PubMedPubMedCentral
16.
Zurück zum Zitat Doak LG, Doak CC, Meade CD (1996) Strategies to improve cancer education materials. Oncol Nurs Forum 23:1305–1312PubMed Doak LG, Doak CC, Meade CD (1996) Strategies to improve cancer education materials. Oncol Nurs Forum 23:1305–1312PubMed
17.
Zurück zum Zitat U.S. National Cancer Institute (2022) Treating smoking in cancer patients: An essential component of cancer care. National Cancer Institute tobacco control monograph 23. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute U.S. National Cancer Institute (2022) Treating smoking in cancer patients: An essential component of cancer care. National Cancer Institute tobacco control monograph 23. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute
18.
Zurück zum Zitat Shields PG et al (2023) Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 21:297–322CrossRefPubMed Shields PG et al (2023) Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 21:297–322CrossRefPubMed
19.
Zurück zum Zitat Sheeran P et al (2019) What works in smoking cessation interventions for cancer survivors? A meta-analysis. Health Psychol 38:855–865CrossRefPubMed Sheeran P et al (2019) What works in smoking cessation interventions for cancer survivors? A meta-analysis. Health Psychol 38:855–865CrossRefPubMed
20.
Zurück zum Zitat Puleo GE et al (2020) A qualitative study of smoking-related causal attributions and risk perceptions in cervical cancer survivors. Psychooncology 29:500–506CrossRefPubMed Puleo GE et al (2020) A qualitative study of smoking-related causal attributions and risk perceptions in cervical cancer survivors. Psychooncology 29:500–506CrossRefPubMed
21.
Zurück zum Zitat U.S. National Cancer Institute (2022) Treating smoking in cancer patients: an essential component of cancer care. National Cancer Institute Tobacco Control Monograph 23. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute U.S. National Cancer Institute (2022) Treating smoking in cancer patients: an essential component of cancer care. National Cancer Institute Tobacco Control Monograph 23. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute
23.
Zurück zum Zitat Livingstone-Banks J, Ordonez-Mena JM, Hartmann-Boyce J (2019) Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev 1:CD001118PubMed Livingstone-Banks J, Ordonez-Mena JM, Hartmann-Boyce J (2019) Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev 1:CD001118PubMed
24.
Zurück zum Zitat Baker TB et al (2016) Enhancing the effectiveness of smoking treatment research: conceptual bases and progress. Addiction 111:107–116CrossRefPubMed Baker TB et al (2016) Enhancing the effectiveness of smoking treatment research: conceptual bases and progress. Addiction 111:107–116CrossRefPubMed
25.
Zurück zum Zitat Baker TB et al (2011) New methods for tobacco dependence treatment research. Ann Behav Med 41:192–207CrossRefPubMed Baker TB et al (2011) New methods for tobacco dependence treatment research. Ann Behav Med 41:192–207CrossRefPubMed
Metadaten
Titel
Development of an Intervention Targeted to Patients with Cancers Not Typically Perceived as Smoking-Related
verfasst von
Ursula Martinez
Thomas H. Brandon
Cherell Cottrell-Daniels
Colleen M. McBride
Graham W. Warren
Cathy D. Meade
Amanda M. Palmer
Vani N. Simmons
Publikationsdatum
06.09.2024
Verlag
Springer US
Erschienen in
Journal of Cancer Education
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-024-02493-y

Neu im Fachgebiet Onkologie

Welche Krebserkrankungen bei Zöliakie häufiger auftreten

Eine große Kohortenstudie hat den Zusammenhang zwischen Zöliakie und gastrointestinalen Krebserkrankungen und inflammatorischen Krankheiten untersucht. Neben gastrointestinalen Tumoren ist auch ein nicht solider Krebs häufiger.

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Knochenmarktransplantat als Chance für ältere AML-Patienten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.